Spire Healthcare Group plc (LON:SPI - Get Free Report)'s share price was up 14.1% during trading on Friday . The company traded as high as GBX 256.50 ($3.47) and last traded at GBX 247 ($3.34). Approximately 9,747,062 shares were traded during mid-day trading, an increase of 563% from the average daily volume of 1,469,073 shares. The stock had previously closed at GBX 216.50 ($2.93).
Analyst Upgrades and Downgrades
Several analysts recently commented on SPI shares. Berenberg Bank reiterated a "buy" rating and issued a GBX 280 price target on shares of Spire Healthcare Group in a research report on Thursday, July 31st. JPMorgan Chase & Co. reduced their target price on shares of Spire Healthcare Group from GBX 309 to GBX 303 and set an "overweight" rating for the company in a report on Tuesday, August 5th. Three investment analysts have rated the stock with a Buy rating, Based on data from MarketBeat, the stock presently has an average rating of "Buy" and a consensus target price of GBX 294.33.
Get Our Latest Report on Spire Healthcare Group
Spire Healthcare Group Stock Performance
The company has a market capitalization of £947.58 million, a PE ratio of 5,119.57, a price-to-earnings-growth ratio of 1.06 and a beta of 0.96. The stock's fifty day simple moving average is GBX 218.99 and its 200-day simple moving average is GBX 203.96. The company has a debt-to-equity ratio of 62.25, a quick ratio of 0.74 and a current ratio of 0.70.
Spire Healthcare Group (LON:SPI - Get Free Report) last released its earnings results on Thursday, July 31st. The company reported GBX 4.10 EPS for the quarter. Spire Healthcare Group had a net margin of 1.96% and a return on equity of 3.82%. As a group, equities analysts predict that Spire Healthcare Group plc will post 15.6634747 earnings per share for the current year.
About Spire Healthcare Group
(
Get Free Report)
Spire Healthcare Group plc, together with its subsidiaries, owns and operates private hospitals and clinics. It offers various treatments in the areas of allergy and infectious diseases, blood tests, bones and joints, bowel treatments, breast screening and surgery, cancer investigations and treatments, cosmetic surgery, cyst removal, and dental surgery, as well as ear, nose, and throat treatments.
Featured Stories
Before you consider Spire Healthcare Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Spire Healthcare Group wasn't on the list.
While Spire Healthcare Group currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.